Ameritas Investment Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Ameritas Investment Partners’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,672	Closed	-$19K	–	3059
2019 Q4	$19K	Hold	4,672	–	–	﹤0.01%	2449
2019 Q3	$23K	Hold	4,672	–	–	﹤0.01%	2330
2019 Q2	$28K	Hold	4,672	–	–	﹤0.01%	2256
2019 Q1	$27K	Hold	4,672	–	–	﹤0.01%	2240
2018 Q4	$63K	Hold	4,672	–	–	﹤0.01%	1678
2018 Q3	$91K	Hold	4,672	–	–	﹤0.01%	1640
2018 Q2	$119K	Buy	4,672 +723	+18%	+$16.9K	0.01%	1426
2018 Q1	$80K	Hold	3,949	–	–	﹤0.01%	1632
2017 Q4	$79K	Hold	3,949	–	–	﹤0.01%	1645
2017 Q3	$66K	Hold	3,949	–	–	﹤0.01%	1710
2017 Q2	$58K	Hold	3,949	–	–	﹤0.01%	1812
2017 Q1	$63K	Buy	+3,949	New	+$57K	﹤0.01%	1698

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Ameritas Investment Partners's DPLO Position: Q1 2020 in Review

Ameritas Investment Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 4,672 shares — an estimated $19K sold.

Ameritas Investment Partners first reported a position in DPLO in Q1 2017 and held it in 12 quarters. The position peaked at $119K in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Ameritas Investment Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Ameritas Investment Partners sold 4,672 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $19K.
Ameritas Investment Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 12 quarters.
Ameritas Investment Partners's DIPLOMAT PHARMACY, INC. position peaked at $119K in Q2 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Ameritas Investment Partners's 13F filing for Q1 2020, filed 13 May 2020.